UFC on ESPN+ 83 Venum Payout; three fighters paid $21,000

(Photo by Suhaimi Abdullah/Zuffa LLC via Getty Images)

SINGAPORE – FightBook MMA has your Venum payout for UFC on ESPN+ 83: Holloway vs. The Korean Zombie. This event took place on Saturday, August 26, 2023, at the Singapore Indoor Stadium in Kallang, Singapore.

in the main event, former UFC featherweight champion Max Holloway fighting out of Waianae, Hawaii took on The Korean Zombie fighting out of Pohang, South Korea. In the co-main event, Anthony Smith fighting out of Omaha, Nebraska faced Ryan Spann fighting out of Beaumont, Texas.

Fighters took home their Venum payout totalling $196,000. Fighters with 1-3 bouts receive $4,000 per appearance; 4-5 bouts get $4,500; 6-10 bouts get $6,000; 11-15 bouts earn $11,000; 16-20 bouts pocket $16,000; and 21 bouts and more get $21,000. Additionally, champions earn $42,000 while title challengers get $32,000. In addition to the based pay, UFC fighters will receive perpetuity royalty payments amounting to 20-30% of any UFC merchandise sold that bears their likeness, according to officials.

UFC on ESPN+ 83 Venum Payout – Holloway vs. The Korean Zombie:

  • Max Holloway: $21,000
  • Chan Sung Jung: $11,000
  • Anthony Smith: $21,000
  • Ryan Spann: $11,000
  • Giga Chikadze: $6,000
  • Alex Caceres: $21,000
  • Rinya Nakamura: $4,000
  • Fernie Garcia: $4,000
  • Erin Blanchfield: $6,000
  • Taila Santos: $6,000
  • Junior Tafa: $4,000
  • Parker Porter: $6,000
  • Waldo Cortes-Acosta: $4,500
  • Lukasz Brzeski: $4,000
  • Garrett Armfield: $4,000
  • Toshiomi Kazama: $4,000
  • Michal Oleksiejczuk: $11,000
  • Chidi Njokuani: $4,500
  • Song Kenan: $6,000
  • Rolando Bedoya: $4,000
  • Billy Goff: $4,000
  • Yusaku Kinoshita: $4,000
  • JJ Aldrich: $11,000
  • Na Liang: $4,000
  • Seungwoo Choi: $6,000
  • Jarno Errens: $4,000

Discover more from FightBook MMA

Subscribe to get the latest posts sent to your email.

Discover more from FightBook MMA

Subscribe now to keep reading and get access to the full archive.

Continue reading